Daniel W. Visscher

27.3k citations

228 papers · 11.0k indexed · 3 hit papers · h-index 58

Impact in

Cancer Research top 0.2%
- Breast Cancer Treatment Studies
Pathology and Forensic Medicine top 0.2%
- Breast Lesions and Carcinomas

Papers in

Cancer Research 118
- Breast Cancer Treatment Studies 84
- Cancer Genomics and Diagnostics 34
Pathology and Forensic Medicine 93
- Breast Lesions and Carcinomas 80

Co-authors: Lynn C. Hartmann Amy C. Degnim Marlene H. Frost Robert A. Vierkant John D. Crissman Wilma L. Lingle Vera J. Suman James N. Ingle
Journals: Breast Cancer Research and Treatment (30 papers)Journal of Clinical Oncology (15 papers)Cancer (15 papers)Cancer Research (8 papers)Human Pathology (7 papers)
Partner nations: United States Australia Netherlands

In The Last Decade

Daniel W. Visscher

227 papers receiving 10.7k citations

Hit Papers

align trajectories log scale

Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes 2005 · 567 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2005 Journal of Clinical Oncology
2005 New England Journal of Medicine
1995 Journal of Clinical Investigation

Peers

Countries citing papers authored by Daniel W. Visscher

Since Specialization

Citations

This map shows the geographic impact of Daniel W. Visscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel W. Visscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel W. Visscher more than expected).

Fields of papers citing papers by Daniel W. Visscher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel W. Visscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel W. Visscher. The network helps show where Daniel W. Visscher may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel W. Visscher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel W. Visscher Line = papers co-authored together Daniel W. Visscher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Association of mammographic density measures and breast cancer “intrinsic” molecular subtypes Breast Cancer Research and Treatment ·Geffen Kleinstern, Christopher G. Scott, Rulla M. Tamimi, Matthew R. Jensen, V. Shane Pankratz, Kimberly A. Bertrand, Aaron D. Norman, Daniel W. Visscher, Fergus J. Couch, Kathleen R. Brandt, John Shepherd, Fang-Fang Wu, Yunn-Yi Chen, Steven R. Cummings, Stacey J. Winham, Karla Kerlikowske, Celine M. Vachon	2021	17
2	Signals from the Metastatic Niche Regulate Early and Advanced Ovarian Cancer Metastasis through miR-4454 Downregulation Molecular Cancer Research ·Subramanyam Dasari, Taruni Pandhiri, Tommaso Grassi, Daniel W. Visscher, Francesco Multinu, Komal Agarwal, Andrea Mariani, Viji Shridhar, Anirban Mitra	2020	12
3	Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy Cancer Prevention Research ·Mark E. Sherman, Robert A. Vierkant, Suneetha Kaggal, Tanya L. Hoskin, Marlene H. Frost, Lori A. Denison, Daniel W. Visscher, Jodi M. Carter, Stacey J. Winham, Matthew R. Jensen, Derek C. Radisky, Celine M. Vachon, Amy C. Degnim	2020	9
4	Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease Breast Cancer Research and Treatment ·Sabina Adhikary, Tanya L. Hoskin, Melody Stallings‐Mann, Muhammad Usman Arshad, Marlene H. Frost, Stacey J. Winham, Alvaro Peña, Delphine J. Lee, Linda M. Murphy, Michele Rakoff, Lori A. Denison, Keith L. Knutson, Derek C. Radisky, Daniel W. Visscher, Amy C. Degnim	2020	4
5	Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer Gynecologic Oncology ·Francesco Multinu, Jun Chen, Joseph D. Madison, Michelle Torres, Jvan Casarin, Daniel W. Visscher, Viji Shridhar, Jamie N. Bakkum‐Gamez, Mark E. Sherman, Nicolas Wentzensen, Andrea Mariani, Marina Walther-António	2020	18
6	Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development Clinical Cancer Research ·Amy C. Degnim, Tanya L. Hoskin, Muhammad Usman Arshad, Marlene H. Frost, Stacey J. Winham, Rushin Brahmbhatt, Alvaro Peña, Jodi M. Carter, Melody Stallings‐Mann, Linda M. Murphy, Erin Miller, Lori A. Denison, Celine M. Vachon, Keith L. Knutson, Derek C. Radisky, Daniel W. Visscher	2017	46
7	ERβ Expression and Breast Cancer Risk Prediction for Women with Atypias Cancer Prevention Research ·Tina J. Hieken, Jodi M. Carter, John R. Hawse, Tanya L. Hoskin, Melanie C. Bois, Marlene H. Frost, Lynn C. Hartmann, Derek C. Radisky, Daniel W. Visscher, Amy C. Degnim	2015	13
8	Clinicopathologic features of breast cancers that develop in women with previous benign breast disease Cancer ·Daniel W. Visscher, Marlene H. Frost, Lynn C. Hartmann, Ryan D. Frank, Robert A. Vierkant, Ann E. McCullough, Stacey J. Winham, Celine M. Vachon, Karthik Ghosh, Kathleen R. Brandt, Ann Farrell, Yaman Tarabishy, Tina J. Hieken, Tufia C. Haddad, Ruth Kraft, Derek C. Radisky, Amy C. Degnim	2015	29
9	Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast Cancer Epidemiology Biomarkers & Prevention ·Zeina G. Khodr, Mark E. Sherman, Ruth M. Pfeiffer, Gretchen L. Gierach, Louise A. Brinton, Roni T. Falk, Deesha A. Patel, Laura Linville, Daphne Papathomas, Susan E. Clare, Daniel W. Visscher, Carolyn Mies, Stephen M. Hewitt, Anna Maria Storniolo, Adrian Rosebrock, Jesus J. Caban, Jonine D. Figueroa	2014	18
10	Immune cell quantitation in normal breast tissue lobules with and without lobulitis Breast Cancer Research and Treatment ·Amy C. Degnim, Rushin D. Brahmbhatt, Derek C. Radisky, Tanya L. Hoskin, Melody Stallings‐Mann, Mark Laudenschlager, Aaron S. Mansfield, Marlene H. Frost, Linda Murphy, Keith L. Knutson, Daniel W. Visscher	2014	67
11	Mammographic density and risk of breast cancer by age and tumor characteristics Breast Cancer Research ·Kimberly A. Bertrand, Rulla M. Tamimi, Christopher G. Scott, Matthew R. Jensen, V. Shane Pankratz, Daniel W. Visscher, Aaron D. Norman, Fergus J. Couch, John Shepherd, Bo Fan, Yunn‐Yi Chen, Lin Ma, Andrew H. Beck, Steven R. Cummings, Karla Kerlikowske, Celine M. Vachon	2013	141
12	Benign Breast Disease and the Risk of Subsequent Breast Cancer in African American Women Cancer Prevention Research ·Michele L. Coté, Julie J. Ruterbusch, Barra Alosh, Subhayu Bandyopadhyay, Elizabeth Kim, Bassam Albashiti, Aldeen Bashar Sharaf, Derek C. Radisky, Marlene H. Frost, Daniel W. Visscher, Lynn C. Hartmann, Warzecha Hind Nassar, Rouba Ali-Femhi	2012	28
13	p16INK4a Expression and Breast Cancer Risk in Women with Atypical Hyperplasia Cancer Prevention Research ·Derek C. Radisky, Marta Santisteban, Hal K. Berman, Mona L. Gauthier, Marlene H. Frost, Carol Reynolds, Robert A. Vierkant, V. Shane Pankratz, Daniel W. Visscher, Thea D. Tlsty, Lynn C. Hartmann	2011	23
14	Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response The Lancet Oncology ·Monica M. Reinholz, Amy K. Bruzek, Daniel W. Visscher, Wilma L. Lingle, Matthew Schroeder, Edith A. Perez, Robert B. Jenkins	2009	77
15	Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease Rheumatology International ·Lizhi Zhang, Daniel W. Visscher, Charanjit S. Rihal, Marie-Christine Aubry	2007	27
16	Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics Cancer ·Daniel W. Visscher, Tracie Wallis, John D. Crissman	1996	41
17	Clinicopathologic significance of p53 immunostaining in adenocarcinoma of the breast. PubMed ·Daniel W. Visscher, F. H. Sarkar, Susan M. Wykes, KanchanS Kothari, Jill A. Macoska, John D. Crissman	1993	14
18	Correlation of DNA ploidy with c-erbB-2 expression in preinvasive and invasive breast tumors. PubMed ·Daniel W. Visscher, F. H. Sarkar, John D. Crissman	1991	15
19	HISTOLOGIC AND IMMUNOPHENOTYPIC EVALUATION OF PRETREATMENT RENAL BIOPSIES IN OKT3-TREATED ALLOGRAFT REJECTIONS Transplantation ·Daniel W. Visscher, John Carey, Heung Kil Oh, N. Turza, Warren Kupin, K.K. Venkat, Richard J. Zarbo	1991	17
20	Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations. PubMed ·Daniel W. Visscher, Richard J. Zarbo, Gordon Jacobsen, Angelos A. Kambouris, Gary B. Talpos, Wael Sakr, John D. Crissman	1990	49

About Daniel W. Visscher

Daniel W. Visscher is a scholar working on Cancer Research, Pathology and Forensic Medicine, Dermatology, Oncology and Immunology and Allergy, having authored 228 papers that have together received 11.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (84 papers), Breast Lesions and Carcinomas (80 papers), Cancer Genomics and Diagnostics (34 papers), Cancer and Skin Lesions (31 papers), Cancer Cells and Metastasis (22 papers), HER2/EGFR in Cancer Research (20 papers), Salivary Gland Tumors Diagnosis and Treatment (17 papers) and AI in cancer detection (14 papers). The work is most often cited by research in Cancer Research (4.3k citations), Pathology and Forensic Medicine (3.2k citations), Oncology (4.7k citations), Dermatology (1.3k citations) and Immunology and Allergy (676 citations). Daniel W. Visscher has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include Lynn C. Hartmann, Amy C. Degnim, Marlene H. Frost, Robert A. Vierkant, John D. Crissman, Wilma L. Lingle, Vera J. Suman, James N. Ingle, F. H. Sarkar and V. Shane Pankratz. Their work appears in journals such as Breast Cancer Research and Treatment, Journal of Clinical Oncology, Cancer, Cancer Research and Human Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact